FOLH1 and posterior cortical atrophy: Radiolabelled monoclonal antibodies (mAb) against PSMA have been used in the clinic for the evaluation of PCa, primarily the 111In-labelled monoclonal antibody, capromab pendetide (Prostascint), which has been commercially available since 1997 for SPECT imaging 2.